178 related articles for article (PubMed ID: 3815349)
21. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
[TBL] [Abstract][Full Text] [Related]
22. N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation.
Oyama T; Kawamoto T; Mizoue T; Yasumoto K; Kodama Y; Mitsudomi T
Anticancer Res; 1997; 17(1B):577-81. PubMed ID: 9066583
[TBL] [Abstract][Full Text] [Related]
23. Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
Marcus PM; Hayes RB; Vineis P; Garcia-Closas M; Caporaso NE; Autrup H; Branch RA; Brockmöller J; Ishizaki T; Karakaya AE; Ladero JM; Mommsen S; Okkels H; Romkes M; Roots I; Rothman N
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):461-7. PubMed ID: 10815690
[TBL] [Abstract][Full Text] [Related]
24. Role of aromatic amine acetyltransferase in human colorectal cancer.
Lang NP; Chu DZ; Hunter CF; Kendall DC; Flammang TJ; Kadlubar FF
Arch Surg; 1986 Nov; 121(11):1259-61. PubMed ID: 3778197
[TBL] [Abstract][Full Text] [Related]
25. Caffeine as a potential indicator for acetylator status.
Rankin RB; Hudson SA; Fell AF
J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563
[TBL] [Abstract][Full Text] [Related]
26. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism].
Lil'in ET; Korsunskaia MP; Meksin VA; Drozdov ES; Nazarov VV
Genetika; 1984 Sep; 20(9):1557-9. PubMed ID: 6542045
[TBL] [Abstract][Full Text] [Related]
27. Sulfadimidine kinetics in patients with various chronic liver diseases.
Horváth T; Past T; Par A; Kádas I; Jávor T
Pol J Pharmacol Pharm; 1988; 40(3):257-64. PubMed ID: 3241767
[TBL] [Abstract][Full Text] [Related]
28. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
[TBL] [Abstract][Full Text] [Related]
29. Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
Palamanda JR; Hickman D; Ward A; Sim E; Romkes-Sparks M; Unadkat JD
Drug Metab Dispos; 1995 Apr; 23(4):473-7. PubMed ID: 7600914
[TBL] [Abstract][Full Text] [Related]
30. Kinetic discrimination of three sulfamethazine acetylation phenotypes.
Chapron DJ; Kramer PA; Mercik SA
Clin Pharmacol Ther; 1980 Jan; 27(1):104-13. PubMed ID: 7351110
[TBL] [Abstract][Full Text] [Related]
31. [Genetic polymorphism in Gilbert-Meulengracht syndrome (GMS)].
Fengler JD; Baumgarten R; Eike E; Eike O; Siegmund W; Franke G; Zschiesche M
Z Gastroenterol; 1993 Feb; 31 Suppl 2():81-2. PubMed ID: 7483725
[TBL] [Abstract][Full Text] [Related]
32. Acetylator phenotype in patients with lung carcinoma--a negative report.
Burgess EJ; Trafford JA
Eur J Respir Dis; 1985 Jul; 67(1):17-9. PubMed ID: 4054252
[TBL] [Abstract][Full Text] [Related]
33. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells.
Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S
Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381
[TBL] [Abstract][Full Text] [Related]
34. [Acetylation processes in chronic alcoholics].
Kovalev IE; Kovalev EN; Seleznev NG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):232-4. PubMed ID: 6711211
[TBL] [Abstract][Full Text] [Related]
35. [Assessment of biotransformation capacity following oral administration of various model substances as cocktail].
Henschel L; Hoffmann A
Z Gastroenterol; 1991 Dec; 29(12):645-9. PubMed ID: 1771946
[TBL] [Abstract][Full Text] [Related]
36. Glucose metabolism in cachectic patients with colorectal cancer.
Holroyde CP; Skutches CL; Boden G; Reichard GA
Cancer Res; 1984 Dec; 44(12 Pt 1):5910-3. PubMed ID: 6388829
[TBL] [Abstract][Full Text] [Related]
37. Colorectal carcinoma in different age groups: a population-based investigation.
Fante R; Benatti P; di Gregorio C; De Pietri S; Pedroni M; Tamassia MG; Percesepe A; Rossi G; Losi L; Roncucci L; Ponz de Leon M
Am J Gastroenterol; 1997 Sep; 92(9):1505-9. PubMed ID: 9317073
[TBL] [Abstract][Full Text] [Related]
38. Relationship between metabolic phenotype of N-acetylation and bladder cancer.
Cui X; Guo R; Xu Z; Wang B; Li C
Chin Med J (Engl); 2000 Apr; 113(4):303-5. PubMed ID: 11775223
[TBL] [Abstract][Full Text] [Related]
39. Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.
Bluhm RE; Adedoyin A; McCarver DG; Branch RA
Clin Pharmacol Ther; 1999 Jun; 65(6):598-605. PubMed ID: 10391665
[TBL] [Abstract][Full Text] [Related]
40. N-acetylator phenotypes in hyperthyroidism.
Siegmund W; Franke G; Meng S; Gothe P; Meng W
Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):397-9. PubMed ID: 3220615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
